Krishna S. Gunturu, MBBS

Krishna Gunturu practices at The Hospital of Central Connecticut in New Britain, Connecticut, part of Hartford HealthCare.

Krishna Gunturu's NPI, 1699881037, was assigned on August 21, 2006. Krishna Gunturu graduated from Yale University School of Medicine in 2012. Krishna Gunturu holds Connecticut license 47112.

Krishna Gunturu's primary practice is The Hospital of Central Connecticut, at 100 Grand Street, New Britain, CT 06050 in Hartford County. The practice phone is (860) 224-5011.

Krishna Gunturu's primary practice is The Hospital of Central Connecticut in New Britain, Connecticut, part of Hartford HealthCare. The medical group on file is The Hospital of Central Connecticut. Dmand AI also links Krishna Gunturu to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Krishna Gunturu practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Krishna Gunturu's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Krishna Gunturu's licenses on file in 3 states: Connecticut, Massachusetts and New Hampshire.

CMS data shows 11 Medicare services from Krishna Gunturu across 1 procedure code in 2024, for 35 Medicare patients. Medicare paid $1,202 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 35 Medicare patients who saw Krishna Gunturu in 2024. The largest group is 75 to 84, with 15 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Krishna Gunturu's median patient age at 71, with 48% women.

In 2024, Krishna Gunturu wrote 137 Medicare Part D claims for 41 patients. 93% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $235 in total drug cost. In 2023, CMS named 293 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Krishna Gunturu for performance year 2024, reported as part of a group. Krishna Gunturu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Krishna Gunturu as offering telehealth.

Dmand AI links 18 papers to Krishna Gunturu, published from 2010 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Immune Checkpoint Inhibitors, Lung Neoplasms and Pancreatic Neoplasms. Krishna Gunturu has published most often in JOP. Krishna Gunturu's most frequent co-authors are Sourbha Satish Dani, MD, Sarju B. Ganatra, MD and Anju Nohria, MD.

Dmand AI links Krishna Gunturu to 10 clinical trials, 4 of them phase 3 studies. 8 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Adenocarcinoma, Bronchiolo-Alveolar. National Cancer Institute (NCI) sponsors the most, 7.

CMS Open Payments shows 63 general payments to Krishna Gunturu from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 84% of the total. Bristol-Myers Squibb Company paid the most, $8,795.

Krishna Gunturu graduated from Yale University School of Medicine in 2012.